Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6033)
All Articles published online
|
Publishing Process of This Article
|
Feb 28, 2014 (publication date) through Dec 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Temraz S, Mukherji D, Shamseddine A. Sequencing of treatment in metastatic colorectal cancer: Where to fit the target? World J Gastroenterol 2014; 20(8): 1993-2004 [PMID: 24616571 DOI: 10.3748/wjg.v20.i8.1993] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i8/1993.htm |
| Number | Citing Articles |
| 1 |
Dylan L. Schaff, Aria J. Fasse, Phoebe E. White, Robert J. Vander Velde, Sydney M. Shaffer. Clonal differences underlie variable responses to sequential and prolonged treatment. Cell Systems 2024; 15(3): 213 doi: 10.1016/j.cels.2024.01.011
|
| 2 |
Alessandro Parisi, Alessio Cortellini, Katia Cannita, Olga Venditti, Floriana Camarda, Maria Alessandra Calegari, Lisa Salvatore, Giampaolo Tortora, Daniele Rossini, Marco Maria Germani, Alessandra Boccaccino, Emanuela Dell’Aquila, Claudia Fulgenzi, Daniele Santini, Michele De Tursi, Nicola Tinari, Pietro Di Marino, Pasquale Lombardi, Susana Roselló Keränen, Marisol Huerta Álvaro, Ina Valeria Zurlo, Domenico Cristiano Corsi, Alessandra Emiliani, Nicoletta Zanaletti, Teresa Troiani, Pasquale Vitale, Riccardo Giampieri, Filippo Merloni, Mario Alberto Occhipinti, Paolo Marchetti, Michela Roberto, Federica Mazzuca, Michele Ghidini, Alice Indini, Ingrid Garajova, Federica Zoratto, Simona Delle Monache, Giampiero Porzio, Corrado Ficorella. Evaluation of Second-Line Anti-VEGF after First-Line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter “SLAVE” Study. Cancers 2020; 12(5): 1259 doi: 10.3390/cancers12051259
|
| 3 |
Chiara Guarini, Teresa Grassi, Gaetano Pezzicoli, Camillo Porta. Beyond RAS and BRAF: HER2, a New Actionable Oncotarget in Advanced Colorectal Cancer. International Journal of Molecular Sciences 2021; 22(13): 6813 doi: 10.3390/ijms22136813
|
| 4 |
Laura A. Barufaldi, Rita de C.R. de Albuquerque, Aline do Nascimento, Luís Felipe L. Martins, Ivan R. Zimmermann, Mirian C. de Souza. Cost-Effectiveness Analysis of Monoclonal Antibodies Associated With Chemotherapy in First-Line Treatment of Metastatic Colorectal Cancer. Value in Health Regional Issues 2023; 37: 33 doi: 10.1016/j.vhri.2023.04.003
|
| 5 |
Koen Degeling, Hui-Li Wong, Hendrik Koffijberg, Azim Jalali, Jeremy Shapiro, Suzanne Kosmider, Rachel Wong, Belinda Lee, Matthew Burge, Jeanne Tie, Desmond Yip, Louise Nott, Adnan Khattak, Stephanie Lim, Susan Caird, Peter Gibbs, Maarten IJzerman. Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry Data. PharmacoEconomics 2020; 38(11): 1263 doi: 10.1007/s40273-020-00951-1
|
| 6 |
Ruihua Xu, Shukui Qin, Weijian Guo, Yuxian Bai, Yanhong Deng, Lei Yang, Zhendong Chen, Haijun Zhong, Hongming Pan, Yongqian Shu, Ying Yuan, Jianfeng Zhou, Nong Xu, Tianshu Liu, Dong Ma, Changping Wu, Ying Cheng, Jianming Xu, Donghui Chen, Wei Li, Sanyuan Sun, Zhuang Yu, Peiguo Cao, Jian Li, Haihui Chen, Jiejun Wang, Shubin Wang, Hongbing Wang, Ning Wang, Bin Zhang, Rubing Han, Weiguo Su, Xiaojun Guo, Jin Li. Subgroup Analysis by Prior Anti-VEGF or Anti-EGFR Target Therapy in FRESCO, a Randomized, Double-Blind, Phase III trial. Future Oncology 2021; 17(11): 1339 doi: 10.2217/fon-2020-0875
|
| 7 |
Alejo Albornoz, Romina Luca, Guillermo Méndez, Marcela Moreno, Federico Esteso, Luisina Bruno, Matías Chacón, Juan Manuel O’Connor. Reexposición de la terapia con Anti-EGFR en pacientes con cáncer colorrectal metastásico RAS/BRAF tipo salvaje. Oncología Clínica 2022; 26(1) doi: 10.56969/oc.v26i1.8
|
| 8 |
Mehmet Artaç, Hasan Şenol Coşkun, Faysal Dane, Bülent Karabulut, Levent Korkmaz, Mustafa Karaağaç, Devrim Çabuk, Senem Karabulut, Nuri Faruk Aykan, Hatice Doruk, Nilüfer Avcı, Nazım Serdar Turhal. Benefit of Bevacizumab-Based Frontline Therapy in Patients with Metastatic Colorectal Cancer (mCRC): a Turkish Oncology Group Study. Journal of Gastrointestinal Cancer 2016; 47(3): 264 doi: 10.1007/s12029-016-9823-7
|
| 9 |
Tadeu Ferreira Paiva, Victor Hugo Fonseca de Jesus, Raul Amorim Marques, Alexandre André Balieiro Anastácio da Costa, Mariana Petaccia de Macedo, Patricia Maria Peresi, Aline Damascena, Benedito Mauro Rossi, Maria Dirlei Begnami, Vladmir Cláudio Cordeiro de Lima. Angiogenesis-related protein expression in bevacizumab-treated metastatic colorectal cancer: NOTCH1 detrimental to overall survival. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1648-4
|
| 10 |
Hye Lee, Eunju Son, Kyoungmin Lee, Yeri Lee, Yejin Kim, Jae-Chul Lee, Yangmi Lim, Minkyu Hur, Donggeon Kim, Do-Hyun Nam. Promising Therapeutic Efficacy of GC1118, an Anti-EGFR Antibody, against KRAS Mutation-Driven Colorectal Cancer Patient-Derived Xenografts. International Journal of Molecular Sciences 2019; 20(23): 5894 doi: 10.3390/ijms20235894
|
| 11 |
Koen Degeling, Martin Vu, Hendrik Koffijberg, Hui-Li Wong, Miriam Koopman, Peter Gibbs, Maarten IJzerman. Health Economic Models for Metastatic Colorectal Cancer: A Methodological Review. PharmacoEconomics 2020; 38(7): 683 doi: 10.1007/s40273-020-00908-4
|
| 12 |
Mostafa Sarvizadeh, Faezeh Ghasemi, Fatemeh Tavakoli, Sara Sadat Khatami, Ebrahim Razi, Hossein Sharifi, Nousin Moussavi Biouki, Mohsen Taghizadeh. Vaccines for colorectal cancer: an update. Journal of Cellular Biochemistry 2019; 120(6): 8815 doi: 10.1002/jcb.28179
|
| 13 |
Se Hee Park, Kon-Young Ji, Hyun Min Kim, Sang Hoon Ma, Seo Young Park, Ju Hui Do, Doo-Byoung Oh, Hyung Sik Kang, Jae Sung Shim, Young Hee Joung. Optimization of the human colorectal carcinoma antigen GA733-2 production in tobacco plants. Plant Biotechnology Reports 2021; 15(1): 55 doi: 10.1007/s11816-020-00657-y
|
| 14 |
Long Bai, Feng Wang, Zhe-zhen Li, Chao Ren, Dong-sheng Zhang, Qi Zhao, Yun-xin Lu, De-shen Wang, Huai-qiang Ju, Miao-zhen Qiu, Zhi-qiang Wang, Feng-hua Wang, Rui-hua Xu. Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer. Medicine 2016; 95(51): e4531 doi: 10.1097/MD.0000000000004531
|
| 15 |
Mingfu Tong, Haiming Liu, Jianyu Hao, Daiming Fan. Comparative pharmacoproteomics reveals potential targets for berberine, a promising therapy for colorectal cancer. Biochemical and Biophysical Research Communications 2020; 525(1): 244 doi: 10.1016/j.bbrc.2020.02.052
|
| 16 |
Ayse Ocak Duran, Halit Karaca, Mehmet Besiroglu, Ibrahim Vedat Bayoglu, Serkan Menekse, Heves Surmeli Yapici, Dogan Yazilitas, Aykut Bahceci, Mukremin Uysal, Alper Sevinc, Ilhan Hacibekiroglu, Asude Aksoy, Ozgur Tanriverdi, Erkan Arpaci, Mevlude Inanc, Faysal Dane, Metin Ozkan. XELOX Plus Bevacizumab vs. FOLFIRI Plus Bevacizumab Treatment for First-line Chemotherapy in Metastatic Colon Cancer: a Retrospective Study of the Anatolian Society of Medical Oncology. Asian Pacific Journal of Cancer Prevention 2015; 15(23): 10375 doi: 10.7314/APJCP.2014.15.23.10375
|
| 17 |
Iakovos Toumazis, Murat Kurt, Artemis Toumazi, Loukia G. Karacosta, Changhyun Kwon. Comparative Effectiveness of Up To Three Lines of Chemotherapy Treatment Plans for Metastatic Colorectal Cancer. MDM Policy & Practice 2017; 2(2) doi: 10.1177/2381468317729650
|
| 18 |
Sally Temraz, Deborah Mukherji, Ali Shamseddine. Dual Inhibition of MEK and PI3K Pathway in KRAS and BRAF Mutated Colorectal Cancers. International Journal of Molecular Sciences 2015; 16(9): 22976 doi: 10.3390/ijms160922976
|
| 19 |
D.P. Modest, S. Pant, A. Sartore-Bianchi. Treatment sequencing in metastatic colorectal cancer. European Journal of Cancer 2019; 109: 70 doi: 10.1016/j.ejca.2018.12.019
|
| 20 |
Orlando Jorge Martins Torres, Marcos Belotto de Oliveira, Paulo Cezar Galvão do Amaral, Eliza Dalsasso Ricardo, Agnaldo Soares Lima, Alexandre Prado de Resende, Renata D’Alpino Peixoto. Colorectal Cancer Liver Metastases. 2020; : 145 doi: 10.1007/978-3-030-25486-5_12
|
| 21 |
Abdosaleh Jafari, Sedighe Sadat Tabatabaei Far, Mehdi Dehghani, Ramin Ravangard. Cost-effectiveness of FOLFOX6+Bevacizumab Versus FOLFOX6+Cetuximab in Stage IV Colorectal Cancer Patients in Shiraz, Iran. Cancer Control 2023; 30 doi: 10.1177/10732748231180679
|